Last edition
News about Market
BELLUS Health Inc, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it has entered into an asset purchase and sale agreement to acquire all of the remaining BLU-5937 and related P2X3 antagonists intellectual property assets.
Market | 24/03/2020 | By Darshana | 515
Sun Pharma Launches RIOMET ER Oral Suspension in the U.S.
Sun Pharmaceutical Industries Ltd. today announced that one of its wholly-owned subsidiaries has launched Riomet ER in the U.S. as an adjunct to diet and exercise to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus. Riomet ER was approved by the U.S. Food and Drug Administration (FDA) on August 29, 2019
Market | 14/03/2020 | By Darshana | 253
India curbs key drug exports as worldwide coronavirus scare grows
India, the world's main supplier of generic drugs, has restricted the export of 26 pharmaceutical ingredients and the medicines made from them, including Paracetamol, a common pain reliever also sold as acetaminophen, as the coronavirus outbreak plays havoc with supply chains
Market | 12/03/2020 | By Darshana | 730
Coronavirus: World pharma supplier India restricts export of some ingredients, drugs
The coronavirus outbreak has disrupted businesses dependent on Chinese supplies and industry professionals say Indian generic drugmakers are likely to face supply shortages from China if the epidemic drags on. Indian pharma companies get almost 70% of the active pharmaceutical ingredients for their medicines from China.
Market | 11/03/2020 | By Darshana | 475
Pharma Industry Likely To Reach $100 Billion: Gowda
D V Sadananda Gowda, Minister of Chemicals and Fertilizers, Govt of India today said that the Indian pharmaceuticals and medical devices sector has the potential to become the world leader and government will provide all necessary support.
Market | 06/03/2020 | By Darshana | 383
Coronavirus impact: Is there hope for Indian pharma beyond Ides of March?
Time is ticking and Indian pharmaceutical units dependent on crucial raw materials from China - active pharmaceutical ingredients and key starting materials to make medicines in India - are waiting and watching developments unfold this month.
Market | 03/03/2020 | By Darshana | 191
Dr Reddy's inks Rs 1,850-crore deal with Wockhardt; to acquire 62 brands & Baddi unit
Dr Reddy's Laboratories on Wednesday announced it would acquire Wockhardt's select divisions of branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives for consideration for Rs 1,850 crore.
Market | 03/03/2020 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy